FIG
CTXR icon

Freed Investment Group’s Citius Pharmaceuticals CTXR Stock Holding History

Freed Investment Group’s Portfolio CTXR Stock Details CTXR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		$107K Buy
+2,116
New +$106K 0.08% 16
2021
Q2 		– Sell
-584
Closed -$26K – 15
2021
Q1 		$26K Sell
584
-556
-49% -$22.1K 0.02% 15
2020
Q4 		$29K Buy
+1,140
New +$29.7K 0.03% 16

Other funds holding CTXR

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Freed Investment Group's CTXR Position: Q3 2021 in Review

Freed Investment Group opened a new position in Citius Pharmaceuticals (CTXR) in Q3 2021: 2,116 shares worth $107K. The stake represents 0.08% of the portfolio and ranks #16 among its holdings. This is a return to the name: Freed Investment Group previously reported a position in CTXR as recently as Q1 2021.

Freed Investment Group first reported a position in CTXR in Q4 2020 and has held it in 3 quarters since. 71 funds tracked by Wall St. Rank hold CTXR as of Q3 2021.

  • Freed Investment Group held 2,116 shares of Citius Pharmaceuticals worth $107K as of Q3 2021.
  • Citius Pharmaceuticals was a new Freed Investment Group position in Q3 2021.
  • Citius Pharmaceuticals made up 0.08% of Freed Investment Group's portfolio in Q3 2021, its #16 holding.
  • Freed Investment Group first reported a position in Citius Pharmaceuticals in Q4 2020 and has held it in 3 quarters since.
  • 71 funds tracked by Wall St. Rank held Citius Pharmaceuticals as of Q3 2021.

Based on Freed Investment Group's 13F filing for Q3 2021, filed 15 Nov 2021.